scispace - formally typeset
L

Leonardo F. Fontenelle

Researcher at Federal University of Rio de Janeiro

Publications -  335
Citations -  8344

Leonardo F. Fontenelle is an academic researcher from Federal University of Rio de Janeiro. The author has contributed to research in topics: Anxiety & Social anxiety. The author has an hindex of 43, co-authored 311 publications receiving 6806 citations. Previous affiliations of Leonardo F. Fontenelle include University of Melbourne & Monash University, Clayton campus.

Papers
More filters
Journal ArticleDOI

Pharmacologic alternatives to antidepressants in posttraumatic stress disorder: a systematic review.

TL;DR: The non-antidepressant agent with the strongest scientific evidence supporting its use in PTSD is risperidone, which can be envisaged as an effective add-on therapy when patients did not fully benefit from previous treatment with SSRIs.
Journal ArticleDOI

The descriptive epidemiology of obsessive-compulsive disorder.

TL;DR: It would be worthwhile to establish a global consensus regarding a standard assessment package for OCD, to produce more cross-culturally valid versions of the key research instruments, and to conduct studies specifically aimed at comparing the sociodemographic, clinical and prognostic aspects of OCD across different countries.
Journal ArticleDOI

Clinical features associated to refractory obsessive–compulsive disorder

TL;DR: The presence of sexual/religious symptoms, low economic status and high modification on family function due to OCD were independently associated with treatment-refractoriness, and future longitudinal studies are warranted to verify if these variables represent predictive factors of treatment non-response.
Journal ArticleDOI

Obsessive-compulsive disorder, impulse control disorders and drug addiction: common features and potential treatments.

TL;DR: The treatment of patients with these disorders must account for alterations in the underlying motivations and neurobiology of the condition, and an initial guide to the specific treatments that future clinical trials might consider in patients with OCD is provided.